The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Lynch Ryan

Reporting owner CIK 0001709271 · See Remarks

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Lynch RyanLynch RyanLynch Ryan · December 15, 2025 · Stock award · Stock Option (Right to Buy)Lynch Ryan · December 15, 2025 · Stock award · Ordinary SharesLynch Ryan · December 15, 2025 · Stock award · Ordinary SharesDec 15, 2025Dec 15, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 15, 2025CRESCENT BIOPHARMA, INC.Stock Option (Right to Buy)Lynch RyanStock award
Dec 15, 2025CRESCENT BIOPHARMA, INC.Ordinary SharesLynch RyanStock award
Dec 15, 2025CRESCENT BIOPHARMA, INC.Ordinary SharesLynch RyanStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: CRESCENT BIOPHARMA, INC.CBIO · company listings
Lynch RyanSee Remarks
Stock awardStock Option (Right to Buy)Derivative security · Code A33,5120Value: 0Currency not specifiedView ↗
Trade: CRESCENT BIOPHARMA, INC.CBIO · company listings
Lynch RyanSee Remarks
Stock awardOrdinary SharesNon-derivative security · Code A4,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: CRESCENT BIOPHARMA, INC.CBIO · company listings
Lynch RyanSee Remarks
Stock awardOrdinary SharesNon-derivative security · Code A8,378Not reported *Value: Not reportedCurrency not specifiedView ↗